Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Experimental Biology and Medicine (Maywood, N.J.)|April 24, 2003
Effects of tin-protoporphyrin IX on blood flow in a rat tumor modelAmel F Khelifi, Vivien E Prise, Gillian M Tozer
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2016
Quantitative Estimation of Tissue Blood Flow RateGillian M Tozer, Vivien E Prise, Vincent J Cunningham
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2009
Quantitative estimation of tissue blood flow rateGillian M Tozer, Vivien E Prise, Vincent J Cunningham
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant dosesGillian M Tozer, Vivien E Prise, Gemma Lewis, et al.
International Journal of Oncology|September 20, 2002
The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant dosesVivien E Prise, Davina J Honess, Michael R L Stratford, et al.
NMR in Biomedicine|March 1, 2002
Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRIRoss J Maxwell, John Wilson, Vivien E Prise, et al.
Microcirculation (New York, N.Y. : 1994)|October 24, 2007
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivoConstantino Carlos Reyes-Aldasoro, Ian Wilson, Vivien E Prise, et al.
Advanced Drug Delivery Reviews|November 3, 2004
Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopyGillian M Tozer, Simon M Ameer-Beg, Jennifer Baker, et al.
NPJ Breast Cancer|April 7, 2021
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancerCraig Davison, Roisin Morelli, Catherine Knowlson, et al.
International Journal of Cancer|May 29, 2013
Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategiesSimon Akerman, Matthew Fisher, Rachel A Daniel, et al.
Pageof 2